Pharmaceutical

Q&A: Increasing awareness around digital therapeutics key to realising full potential

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest trends and challenges in the digital therapeutics space.

Mar 16, 2024 - 00:00
Q&A: Increasing awareness around digital therapeutics key to realising full potential
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest trends and challenges in the digital therapeutics space.
Read the original article

Tags:

Previous Article

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

Next Article

Xcovery edges closer to FDA approval for NSCLC ALK inhibitor

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Artificial intelligence is set to power the future of healthcare provision

Artificial intelligence is set to power the future of h...

Aug 8, 2023

UK charities condemn continued drug shortages

UK charities condemn continued drug shortages

Apr 13, 2024

STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care

STAT+: Brigham and Women’s exec opens up about the Dana...

Sep 28, 2023